New Members Join the Alliance
The CCRA is pleased to announce the addition of two new member organizations: Bladder Cancer Canada and Myeloma Canada, and we welcome new representatives: Michelle Colero, Executive Director, Bladder Cancer Canada and Martine Elias, Executive Director, Myeloma Canada.
Bladder Cancer Canada is the only national patient advocacy organization for the over 80,000 Canadians living with bladder cancer. In addition to its patient support mission, targeted research funding is an important organizational priority.
Myeloma Canada is the only national charitable patient organization created by, and for, Canadians impacted by myeloma. A patient-driven approach to research prioritization guides it research funding decision-making.
We look forward to learning about and from our newest members!

CCRA’s Patient Involvement in Cancer Research Program (known as PIP) will be offered virtually in the fall of 2021. This program is designed for cancer patients, survivors, and caregivers with an interest in learning more about cancer research and how they can contribute to the re...
The CIHR Institute of Cancer Research is pleased to announce the open call for applications for its 2025 Early Career Researcher (ECR) Workshop, in partnership with the Canadian Cancer Research Alliance, Canadian Cancer Society, Cancer Research Society, Ontario Institute f...